NITRATE TOLERANCE IN HEART-FAILURE - DIFFERENTIAL VENOUS, PULMONARY AND SYSTEMIC ARTERIAL EFFECTS

被引:19
作者
MAKHOUL, N [1 ]
DAKAK, N [1 ]
FLUGELMAN, MY [1 ]
MERDLER, A [1 ]
SHEFER, A [1 ]
SCHNEEWEISS, A [1 ]
HALON, DA [1 ]
LEWIS, BS [1 ]
机构
[1] LADY DAVIES CARMEL HOSP,DEPT CARDIOL,7 MICHAL ST,IL-34362 HAIFA,ISRAEL
关键词
D O I
10.1016/0002-9149(90)91307-R
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The hemodynamic profile of tolerance to intravenous nitroglycerin was studied in 9 patients with New York Heart Association Class III to IV congestive heart failure. After rapid dosage build-up to the maximal tolerated dose (decrease in pulmonary wedge pressure to 10 mm Hg or systolic blood pressure to 90 mm Hg), nitroglycerin (525 ± 548 μg/min) was administered at a constant continuous intravenous infusion for a total of 24 hours. The extent of nitrate tolerance at 24 hours was calculated as the percentage loss of the benefit achieved at time of peak effect of nitroglycerin. Tolerance had a different time course and magnitude in the venous, arterial and pulmonary circulations. At 24 hours, right atrial pressure and pulmonary vascular resistance returned to control values in most patients, while 40 to 50% of the effect on systemic vascular resistance, cardiac index and pulmonary wedge pressure was maintained. These findings emphasize the importance of precise definitions in studies relating to nitrate tolerance. © 1990.
引用
收藏
页码:J28 / J31
页数:4
相关论文
共 22 条
  • [1] TOLERANCE TO ORGANIC NITRATES
    ABRAMS, J
    [J]. CIRCULATION, 1986, 74 (06) : 1181 - 1185
  • [2] HEMODYNAMIC-EFFECTS OF NITROGLYCERIN AND LONG-ACTING NITRATES
    ABRAMS, J
    [J]. AMERICAN HEART JOURNAL, 1985, 110 (01) : 216 - 224
  • [3] NITRATES - MODE OF ACTION AT A CELLULAR-LEVEL
    AHLNER, J
    AXELSSON, KL
    [J]. DRUGS, 1987, 33 : 32 - 38
  • [4] COSSUM PA, 1986, J PHARMACOL EXP THER, V237, P959
  • [5] INCIDENCE OF EARLY TOLERANCE TO HEMODYNAMIC-EFFECTS OF CONTINUOUS INFUSION OF NITROGLYCERIN IN PATIENTS WITH CORONARY-ARTERY DISEASE AND HEART-FAILURE
    ELKAYAM, U
    KULICK, D
    MCINTOSH, N
    ROTH, A
    HSUEH, W
    RAHIMTOOLA, SH
    [J]. CIRCULATION, 1987, 76 (03) : 577 - 584
  • [6] IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739
  • [7] DIFFERENCE IN NITROGLYCERIN DOSE-RESPONSE IN THE VENOUS AND ARTERIAL BEDS
    IMHOF, PR
    OTT, B
    FRANKHAUSER, P
    CHU, LC
    HODLER, J
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (06) : 455 - 460
  • [8] DOSE REQUIREMENTS AND HEMODYNAMIC-EFFECTS OF TRANSDERMAL NITROGLYCERIN COMPARED WITH PLACEBO IN PATIENTS WITH CONGESTIVE HEART-FAILURE
    JORDAN, RA
    SETH, L
    HENRY, DA
    WILEN, MM
    FRANCIOSA, JA
    [J]. CIRCULATION, 1985, 71 (05) : 980 - 986
  • [9] RAPIDLY DEVELOPING TOLERANCE TO TRANSDERMAL NITROGLYCERIN IN CONGESTIVE-HEART-FAILURE
    JORDAN, RA
    SETH, L
    CASEBOLT, P
    HAYES, MJ
    WILEN, MM
    FRANCIOSA, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1986, 104 (03) : 295 - 298
  • [10] CENTRAL AND REGIONAL HEMODYNAMIC-EFFECTS OF INTRAVENOUS ISOSORBIDE DINITRATE, NITROGLYCERIN AND NITROPRUSSIDE IN PATIENTS WITH CONGESTIVE HEART-FAILURE
    LEIER, CV
    BAMBACH, D
    THOMPSON, MJ
    CATTANEO, SM
    GOLDBERG, RJ
    UNVERFERTH, DV
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (06) : 1115 - 1123